Carmen Bria, PhD, is a consultant at Syner-G BioPharma Group, specializing in analytical chemistry, CMC strategy, and regulatory support. With a proven track record in method development and validation, he has led CMC analytical and stability programs and authored regulatory submissions (INDs and BLAs) for biologics, integrating technical insight with strategic objectives to accelerate development timelines. Prior roles include analytical development positions at Neva Analytics, Tolmar Pharmaceuticals, and PPG Industries. Carmen holds a PhD in Applied Chemistry from Colorado School of Mines and a BS in Chemistry from the University of Puget Sound.